{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:00:00Z","timestamp":1785214800538,"version":"3.55.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Musculoskeletal trauma is exceedingly common and experiences a high incidence of complications, including bone non-union. Previous studies have implicated a dysregulated systemic immune response after injury as an important factor contributing to complications. We have previously identified a negative correlation between circulating myeloid-derived suppressor cells (MDSCs) and bone regeneration in a rat model of composite bone and muscle trauma. MDSCs are an immature, heterogeneous cell population of myeloid lineage that expands after injury and possesses potent immunosuppressive functions including the inhibition of T cells and expansion of regulatory T cells (Tregs), which could contribute to poor outcomes. As such, they may represent a novel therapeutic target in bone trauma. All-trans retinoic acid (ATRA) is a vitamin A derivative that has previously been shown to reduce MDSCs in cancer models by promoting their differentiation into mature myeloid cell populations. However, ATRA\u2019s effects on MDSCs have not been explored in the context of trauma. Here, we investigated the effects of ATRA on peripheral blood immune cells both\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    using a rodent model of bone and muscle trauma. Treatment with ATRA depleted MDSCs in blood derived from traumatized rats\n                    <jats:italic>in vitro<\/jats:italic>\n                    . Further,\n                    <jats:italic>in vivo<\/jats:italic>\n                    studies revealed that a specific subset of MDSCs were depleted by systemic ATRA administration. Tregs were also depleted and correlated negatively with endpoint bone healing, although healing overall was not altered by ATRA treatment. Additionally, higher doses of ATRA had the unanticipated effect of increasing rather than decreasing circulating MDSC levels. Further studies will be necessary to develop and optimize immunomodulatory interventions targeting systemic immune dysregulation after trauma and to determine whether such interventions possess the potential to improve functional bone regenerative outcomes.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1683993","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:45Z","timestamp":1785212745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic administration of all-trans retinoic acid modulated circulating immune cells but failed to improve healing in a preclinical model of musculoskeletal trauma"],"prefix":"10.3389","volume":"17","author":[{"given":"Tyler","family":"Guyer","sequence":"first","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Gill","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Leguineche","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Link","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Jones","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie E.","family":"Williams","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia K.","family":"Strait","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly Ann","family":"Hastings","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lin","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drishti","family":"Maniar","sequence":"additional","affiliation":[{"name":"Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University","place":["Atlanta, GA, United States"]},{"name":"Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnendu","family":"Roy","sequence":"additional","affiliation":[{"name":"Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University","place":["Atlanta, GA, United States"]},{"name":"Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology","place":["Atlanta, GA, United States"]},{"name":"Department of Biomedical Engineering, Vanderbilt University","place":["Nashville, TN, United States"]},{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center","place":["Nashville, TN, United States"]},{"name":"Department of Chemical and Biomolecular Engineering, Vanderbilt University","place":["Nashville, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Guldberg","sequence":"additional","affiliation":[{"name":"University of Oregon","place":["Eugene, OR, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2017.1321351","article-title":"The risk of non-union per fracture: current myths and revised figures from a population of over 4 million adults","volume":"88","author":"Mills","year":"2017","journal-title":"Acta Orthopaedica"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.2775","article-title":"Epidemiology of fracture nonunion in 18 human bones","volume":"151","author":"Zura","year":"2016","journal-title":"JAMA Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-42","article-title":"Tibia shaft fractures: costly burden of nonunions","volume":"14","author":"Antonova","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"111779","DOI":"10.1016\/j.injury.2024.111779.","article-title":"Long-term patient reported outcomes after revision surgery for lower extremity nonunion: a retrospective cohort study","volume":"55","author":"Wagner","year":"2024","journal-title":"Injury"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-011-1205-7","article-title":"Inflammatory phase of bone healing initiates the regenerative healing cascade","volume":"347","author":"Schmidt-Bleek","year":"2012","journal-title":"Cell Tissue Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e318256e000","article-title":"Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care","volume":"72","author":"Gentile","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2017889118","article-title":"Early systemic immune biomarkers predict bone regeneration after trauma","volume":"118","author":"Cheng","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0064-8","article-title":"Innate immune responses to trauma","volume":"19","author":"Huber-Lang","year":"2018","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2016.08.006","article-title":"Postinjury inflammation and organ dysfunction","volume":"33","author":"Sauaia","year":"2017","journal-title":"Crit Care Clin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2008.06.010","article-title":"The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients","volume":"29","author":"Ward","year":"2008","journal-title":"Clin Chest Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2016.12.001","article-title":"Persistent inflammation, immunosuppression and catabolism syndrome (PICS)","volume":"33","author":"Mira","year":"2017","journal-title":"Crit Care Clin"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900066","article-title":"MODS\/SIRS: result of an overwhelming inflammatory response","volume":"20","author":"Goris","year":"1996","journal-title":"World J Surg"},{"key":"B13","article-title":"Dynamic changes in trauma-induced myeloid-derived suppressor cells after polytrauma are associated with an increased susceptibility to infection","volume":"10","author":"Cheng","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.1038\/s41598-017-13019-6","article-title":"MDSCs are induced after experimental blunt chest trauma and subsequently alter antigen-specific T cell responses","volume":"7","author":"H\u00fcsecken","year":"2017","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","article-title":"Myeloid-derived suppressor cells inhibit T cell activation by depleting cystine and cysteine","volume":"70","author":"Srivastava","year":"2010","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28622","article-title":"Subpopulations of myeloid-derived suppressor cells (MDSC) impair T cell responses through independent nitric oxide-related pathways","volume":"134","author":"Raber","year":"2014","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800695115","article-title":"Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers","volume":"115","author":"Feng","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1038\/s41598-018-21856-2","article-title":"Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of Tregs and attenuation of rheumatoid inflammation in mice","volume":"8","author":"Park","year":"2018","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00129","article-title":"Critical role of myeloid-derived suppressor cells in tumor-induced liver immune suppression through inhibition of NKT cell function","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10928","article-title":"IL-17-producing \u03b3\u03b4 T cells enhance bone regeneration","volume":"7","author":"Ono","year":"2016","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1039\/d0bm01728k","article-title":"BMP-2 delivery strategy modulates local bone regeneration and systemic immune responses to complex extremity trauma","volume":"9","author":"Vantucci","year":"2021","journal-title":"Biomater Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.934773\/full","article-title":"Systemic immune modulation alters local bone regeneration in a delayed treatment composite model of non-union extremity trauma","volume":"9","author":"Vantucci","year":"2022","journal-title":"Front Surg"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120405","article-title":"Development of systemic immune dysregulation in a rat trauma model of biomaterial-associated infection","volume":"264","author":"Vantucci","year":"2021","journal-title":"Biomaterials"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201606-1143oc","article-title":"Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis","volume":"196","author":"Uhel","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2495","article-title":"Targeting MDSC differentiation using ATRA: a phase I\/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma","volume":"29","author":"Tobin","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.08.007","article-title":"Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with ipilimumab","volume":"63","author":"Tobin","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2593","article-title":"Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells","volume":"67","author":"Nefedova","year":"2007","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0103010","article-title":"Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species","volume":"74","author":"Kusmartsev","year":"2003","journal-title":"J Leukocyte Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"9619","DOI":"10.1038\/s41598-022-13855-1","article-title":"Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer","volume":"12","author":"Liang","year":"2022","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEC.2012.0290","article-title":"Attenuated human bone morphogenetic protein-2\u2013mediated bone regeneration in a rat model of composite bone and muscle injury","volume":"19","author":"Willett","year":"2013","journal-title":"Tissue Eng Part C Methods"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103562","article-title":"Treatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects","volume":"9","author":"Kang","year":"2014","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"237ra67","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Highfill","year":"2014","journal-title":"Sci Transl Med"},{"key":"B38","article-title":"Cancer therapy targeting tetraspanin 33 (tspan33) in myeloid derived suppressor cells","author":"Sukhatme","year":"2018"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/428359","article-title":"Effects of BMP-2 dose and delivery of microvascular fragments on healing of bone defects with concomitant volumetric muscle loss","volume":"37","author":"Ruehle","year":"2019","journal-title":"J Orthop Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biomaterials.2010.08.074","article-title":"An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects","volume":"32","author":"Kolambkar","year":"2011","journal-title":"Biomaterials"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V76.9.1710.1710","article-title":"All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship","volume":"76","author":"Chomienne","year":"1990","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2543","article-title":"Effects of all-trans retinoic acid on VEGF and HIF-1\u03b1 expression in glioma cells under normoxia and hypoxia and its anti-angiogenic effect in an intracerebral glioma model","volume":"10","author":"Liang","year":"2014","journal-title":"Mol Med Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/bot.0b013e31818e43dd","article-title":"Complications following limb-threatening lower extremity trauma","volume":"23","author":"Harris","year":"2009","journal-title":"J Orthop Trauma"},{"key":"B44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jor.24186","article-title":"Impaired bone healing following treatment of established nonunion correlates with serum cytokine expression","volume":"37","author":"Cheng","year":"2019","journal-title":"J Orthop Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nor042","article-title":"Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma","volume":"13","author":"Raychaudhuri","year":"2011","journal-title":"Neuro Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03105.x","article-title":"Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma","volume":"128","author":"Zhao","year":"2009","journal-title":"Immunology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01560","article-title":"All-trans retinoic acid promotes an M1- to M2-phenotype shift and inhibits macrophage-mediated immunity to Leishmania major","volume":"8","author":"Vellozo","year":"2017","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4666","article-title":"Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells","volume":"181","author":"Sinha","year":"2008","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"7863","DOI":"10.1038\/s41467-024-51353-2","article-title":"Local administration of regulatory T cells promotes tissue healing","volume":"15","author":"Nayer","year":"2024","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-023-1024-8","article-title":"A distinct \u201crepair\u201d role of regulatory T cells in fracture healing","volume":"18","author":"Wu","year":"2024","journal-title":"Front Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.10.6195","article-title":"Mechanisms of dimethyl sulfoxide augmentation of IL-1\u03b2 production 1","volume":"174","author":"Xing","year":"2005","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152538","article-title":"Dmso represses inflammatory cytokine production from human blood cells and reduces autoimmune arthritis","volume":"11","author":"Elisia","year":"2016","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1101\/2024.04.09.588752","article-title":"All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axis","volume-title":"Biorxiv","author":"Rao","year":"2024"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2017.0232","article-title":"The immunomodulatory role of BMP-2 on macrophages to accelerate osteogenesis","volume":"24","author":"Wei","year":"2018","journal-title":"Tissue Eng Part A"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEB.2015.0357","article-title":"A review of the clinical side effects of bone morphogenetic protein-2","volume":"22","author":"James","year":"2016","journal-title":"Tissue Eng Part B Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1683993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:47Z","timestamp":1785212747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1683993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2026.1683993"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1683993","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1683993"}}